×
(NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") and ...
According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.25. The reported EPS for the same ...
Rating (5,975)
BioLife Solutions (BLFS) will release its next earnings report on May 9, 2024. In the last quarter BioLife Solutions reported -$0.342 EPS in relation to ...
Missing: relations | Show results with:relations
A leading provider of bioproduction tools and services to the life sciences and broader biopharma markets. Learn more.
Find the latest BioLife Solutions, Inc. (BLFS) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: relations | Show results with:relations
BioLife Solutions Investor Presentation : January 2024 ... BA Economics & International Relations, MBA; 30+ years in senior ... NASDAQ: BLFS.
Feb 20, 2024 · Media & Investor Relations. At the Company Troy Wichterman Chief Financial Officer (425) 402-1400 twichterman@biolifesolutions.com. Cision ...